Vein graft disease is a chronic inflammatory disease and limits the late results of coronary revascularization. Calcitonin gene-related peptide (CGRP) inhibits macrophages infiltrated and inflammatory mediators, we hypothesized that transfected CGRP gene inhibits macrophages 
Introduction
Autologous vein is usually using a material in artery rebuild,But, it was exposed to ischemia、trauma、inflammatory reaction and received high pressure and so on , embolism、spasm were appearred in early period, neointimal thickening and atherosclerosis were appearred in later,angioma occurred by chance,the phenomenon is vein graft disease.It is affected severely clinic effect of coronary artery bypass grafting （CABG）and peripheral vascular disease operation [1, 2, 3] .Previous data shown that inflammatory cells infiltrated and inflammatory mediators released in the vein grafts, Macrophages and inflammatory mediators stimulated hyperplasia of vascular smooth muscle cells and neointimal thickening [4, 5] .
Calcitonin gene-related peptide（CGRP）is a 37-amino acid biological activity neuropeptide,
The nerve contained CGRP wraped in larger part vascular [6, 7] . Previous studies have shown that CGRP inhibits inflammatory cells and inflammatory mediators [8, 9] , protects endothelial function [10, 11] and inhibits vascular smooth muscle cells hyperplasia [12, 13] .Accordingly, we sought to evaluate the effects of CGRP, using mosaic adeno-associated virus vectors gene transfer, on development of the vein graft disease in rabbits.
Results

Gene Expression in Vein Grafts
Gene expression of an AAV2/1.CGRP at 4 weeks after infection and grafting was noted only in the AAV2/1.CGRP group vein grafts (Fig 1A) . Both AAV2/1.CGRP group grafts and plasmid cDNA (positive control) yielded an identical cDNA product (227 bp), The AAV2/1.LacZ group and saline group and saline did not show CGRP RNA expression (Fig. 1A) .
Gene expression of an AAV2/1.LacZ at 4 weeks, processed with X-gal chromagen for β-galactosidase, demonstrates excellent gene transfer with AAV2/1.LacZ (Fig. 1B) . Endogenous β-galactosidase activity was not detected in saline group and AAV2/1.CGRP group vein grafts. PCR cDNA products are visualized on agarose gels stained with ethidium bromide. 
CGRP Reduces Vein Graft Disease in rabbits
The intimal and medial area in EVG-stained cross sections was measured at 4 weeks( Fig. 2A) .
AAV2/1.CGRP group significantly suppressed intimal hyperplasia as compared to AAV2/1.LacZ 4 group and saline group (37% and 39% less, respectively; P<0.001, Fig. 2B ). Moreover, the anti-inflammatory effect of CGRP, as infiltration of macrophages into the graft wall is also considered to play an important role in the response to vein graft disease. Immunohistochemical study demonstrated that infiltration of macrophages was markedly increased in specimens in AAV2/1.LacZ group or Saline group, while recruitment of macrophages was significantly inhibited by transfection of AAV2/1.CGRP (Fig. 3) . 
Inflammation Mediating Molecules mRNA Expression
Expression levels of inflammation mediating molecules in vein graft samples of all rabbit groups were higher than those of AAV2/1.CGRP group (Fig. 4) . The AAV2/1.CGRP gene transfection significantly inhibited inflammation mediating molecules MCP-1、 TNF-α、 iNOS 、 MMP-9 mRNA in vein grafts. The most significantly up-regulated inflammation mediating molecules mRNA was MMP-9, which displayed higher mRNA levels in the AAV2/1.LacZ group and saline group controls.
Fig. 4 Mean inflammation-mediating molecules mRNA levels in the vein grafts. All vein grafts
were tested for inflammation mediating molecules mRNA levels by quantitative real-time PCR using GAPDH as internal standard. Each specific inflammation mediating molecules is indicated on the figure. *P < 0·05 AAV2/1.CGRP group versus AAV2/1.LacZ group and saline group(n=7 per group).
Discussion
In the past, Kilian et al [15] showed transfected native rabbit jugular veins with recombinant AAV vector,Moreover, low immunogenicity of AAV may also allow long-term transgene expression; Sen et al [16] showed that AAV1 have advantages over AAV2 for vascular gene delivery at low titres; Stachler et al [17] showed that mosaic AAV1 particles in a 50-100-fold enhancement in endothelial cell gene transfer and suggest that mosaic virions hold significant promise for targeted gene delivery to the vasculature.In the present study we showed that recombinant mosaic AAV2/1
facilitates an effective gene transfection in an autologous rabbit vein grafts model. Our data have
shown that AAV2/1.CGRP was transfected effectively to vein grafts( MCP-1 is a potent monocyte chemotactic and activating factor belonging to the C-C family of intercrine cytokines,which is synthesized by endothelial cells, smooth muscle cells, fibroblasts, and monocytes/ macrophages, all of which are present in vein grafts [18, 19] . Upregulation of MCP-1 gene expression in vein grafts results in the recruitment of monocytes and tissue macrophages to the vein wall, which leads to intimal hyperplasia (IH). The correlation between monocyte/ macrophage infiltration and IH suggests a critical role for these cells in IH development [19, 20] .
Previous studies have shown anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo [21, 22, 23] . Li et al [8] report intrinsic and extrinsic peptide CGRP inhibits IL-1 -induced MCP-1 secretion in an autocrine/paracrine mode and suppresses the IL-1 -evoked ROS-NF-B cascade via cAMP signaling. It is also known that CGRP suppressed the number of macrophage colonies formed [24] .
In the present study, Our data shown that AAV2/1.CGRP-treated suppressed MCP-1 mRNA and macrophage (Fig. 3, Fig. 4A ), It is possible mechanism that CGRP-treated vein graft disease by suppressed MCP-1 and macrophages.
Macrophages express inducible nitric oxide synthase (iNOS) and tumour necrosis factor alpha (TNF-α) and multiple metalloproteinases [4, 25, 26] ，A number of previous studies have suggested that an essential role for MMP-9 activation in the development of vascular SMC proliferation, migration and neointima formation [27, 28] . TNF-α-induced MMP-9 production and promoter activity [29] , effectively suppresses TNF-alpha-induced VSMC migration through the selective inhibition of MMP-9 expression [30, 31] . Likewise, iNOS increase the expression of matrix metalloproteinase-9 in vascular smooth muscle, iNOS is related with the development of atherosclerosis [32, 33, 34] .TNF-α and iNOS generated by macrophages can be inhibited by CGRP [35, 36] .Our study shown that CGRP inhibit macrophages infiltration and inflammation mediating molecules TNF-αand iNOS, especially MMP-9( Fig. 3, Fig. 4B、C、D ),Accordingly,We deduced that the macrophages and inflammation mediating molecules are played an essential role in the development vein graft disease, CGRP suppresses vein graft disease by inhibits macrophages infiltration and inflammation mediating molecules.
In conclusion, Our study demonstrated that AAV2/1.CGRP gene transfer via ex vivo inhibited macrophage infiltration and inflammation mediating molecules mRNA of MCP-1、TNF-α、iNOS and MMP-9,dramatically reduced vessel wall thickening in vein graft disease. These findings highlight the importance of AAV2/1.CGRP gene transfer in clinic treatment vein graft disease.
Materials and methods
1.Rabbit Vein Graft Model and ex Vivo Gene Transfer
25 Adult male New Zealand white rabbits (2.5 ～ 3.0kg) were anesthetized with an intramuscular injection of pentobarbital (3mg/kg; sigma), Neither mechanical ventilation nor supplemental intravenous fluid administration was required. Under general anesthesia and using a sterile technique, the right jugular vein and carotid artery were exposed through a midline incision.
An approximately 3.0 cm segment of the jugular vein, lacking valves, was isolated by ligation of the proximal and distal vein for the autologous reversed-vein graft. A small venotomy was made in the distal vein. About a 300μL volume of AAV2/1.CGRP(at 5×10 10 vg/ml, n=8), AAV2/1.LacZ (at 5×10 10 vg/ml, n=9) or Saline (n=8) was injected into the lumen of the isolated vein and maintained expanded.Then resected the segment of the jugular vein and put it into a tube contained 2ml AAV2/1.CGRP(at 5×10 10 vg/ml) or AAV2/1.LacZ(at 5×10 10 vg/ml) or Saline in 30 minutes at room temperature（Fig 5）.
After systemic heparinization (1000 IU), the ipsilateral common carotid artery was dissected and clamped. End-to-side interpositional grafting of the jugular vein segment to the carotid artery was performed using 9-0 nylon continuous running suture. Arterial blood flow was restored to the carotid artery and vein graft. The neck incision was closed, and the animals were placed under a warming light until fully recovered from anesthesia. After recovery, the rabbits were maintained on 
2.Harvest and Processing of Tissue Samples
The AAV2/1.CGRP group 、AAV2/1.LacZ group and Saline group dyed 1、2、1 rabbits within 4 weeks, Dead rate is 16﹪(4/25). After induction of anesthesia and after confirming patency of the vessels studied, animals were euthanized with an overdose of anesthetic. Vein grafts harvested at 4
weeks (n=7 per group), A 2.5mm long middle segment of vein grafts(n=7 per group) was fixed with 10% neutral-buffered formalin to do histological study; A 2.5mm long middle segment of vein grafts(n=2 per group) and residual vein grafts(n=7 per group) were immediately snap-frozen with liquid nitrogen, then stored at -70°C for later study.
3.Histological Study
The fixed in 10% neutral buffered formalin vein grafts processed for routine paraffin embedding.
Two sections were taken from the midportion of the vein grafts. Cross-sections (5 μm) were stained with both hematoxylin and eosin (HE) and elastic van Gieson's stain (EVG) in a standard manner. Intimal and medial areas were calculated by quantitative morphometric analysis with a computerized sketching program. The ratio of intimal to medial area was also calculated.
X-gal Staining
β-Galactosidase, an index of successful AAV1∕2.lacZ infection, was documented with X-gal chromagen in specimens,2 Samples AAV2/1.CGRP group and 2 samples saline group as negative controll. 6 Samples tissue samples were taken from -80℃ refrigeratory, Whole tissue X-gal chromagen staining was done according to exponent（GENMED）, a segment of vein was also fixed in 10% formalin and embedded in paraffin after X-gal chromagen staining. 8μm-thick cross section samples were cut from the paraffin blocks, then observed at ×400 magnification for evidence of production of β-galactosidase. Tissue cell stained positive for β-galactosidase is blue.
Immunohistochemical Study
Paraffin-embedded vein graft sections were stained for macrophage using a mouse monoclonal anti-CD68 antibody (Dako),For negative control experiments, the primary antibody was omitted.
Immunohistochemical staining was performed using the immunoperoxidase avidin-biotin complex system. Then, 5-μ m sections were deparaffinized, rehydrated before blocking endogenous peroxidase activity with 3% hydrogen peroxidase and preincubated with 5% normal horse serum in sodium phosphate-buffered saline (PBS) for 30 min. Diluted primary antibodies (1:30) were then applied to the sections, and these sections were incubated overnight at 4 °C. With intervening washing in PBS, they were serially incubated with biotinylated anti-mouse IgG in PBS and avidin-biotinylated horseradish peroxidase complex in PBS for 30 min, Immune complexes were localized using 0.05% 3,3 ′ -diaminobenzidine (DAB), and slides were counterstained with hematoxylin.
Reverse Transcription-Polymerase Chain Reaction of CGRP
Total RNA was isolated from rabbit vein graft tissues by use of Trizol reagent (Invitrogen), then reverse-transcribed using a one-step reverse transcription-polymerase chain reaction (RT-PCR) kit (Invitrogen) with oligo(dT) primers. Then, the sequence of CGRP was amplified by PCR (annealing at 58°C for 45 seconds, extension at 72°C for 1minute, 30 cycles), The CGRP primers refer to table1. Also, Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (The primers design was refered data of Zucker ,et al [14] ) was amplified as a reference use of a primer pair specific to rabbit GAPDH at the same reaction condition for 30 cycles.
7.Real-Time Polymerase Chain Reaction
RT-PCR reactions were performed on all rabbits' mRNA at the same time for each individual inflammation-mediating molecules tested. First-strand cDNA synthesis was performed from 1.3μg
of total RNA in 20 μL volumes with oligo(dT) priming, using Superscript First-strand Synthesis System (Invitrogen). PCR amplification was performed with Power SYBR Green PCR Master Mix (ABI),The molecules primers refer to table1.The reaction was incubated at 50°C for 2 minutes, 95°C for 10 minutes, followed by 40 cycles of 15 seconds at 95°C, 1 minute at 60°C with use of a ABI 7000 sequence detection system. In all assays, the specificity of the final amplified products was verified by heat dissociation curve analysis with the use of software supplied by the manufacturer. 
